Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 4, 2003

View Archived Issues

Roxifiban does not activate platelets from healthy volunteers

Pozen submits MT-100 NDA

Medivir licenses MIV-150 to Population Council

Kyorin and Eisai amend Maxalt agreement

MOR-201 program discontinued in Q2 at MorphoSys

Oxagen identifies novel diabetes gene

FDA approval for Rebetol in pediatric hepatitis C

Probactrix controls HIV-associated diarrhea in clinical trial

Health Canada grants clearance for initiation of phase II studies of Infecton

Pfizer returns P-57 rights to Phytopharm

Strategic review and Q2 results at Shire

Combination therapies for allergic diseases comprising an anti-IgE antibody and antiallergic agent

Use of amylin agonists for reducing triglyceride levels

Adenosine receptor ligands and their use in depression and other disorders

IGF-I peptides useful in ophthalmology and dermatology

Bristol-Myers Squibb presents new antiviral compounds

New nuclear hormone receptor modulators synthesized at BMS

Camptothecin encapsulated in cationic liposomes targets tumor blood vessels

LipoRed: a cationic liposome-based neovascular imaging agent

AVE-8062A: a tumor vasculature targeting agent with promising antitumor activity

Additional mechanism of action for IGN-311: inhibition of growth factor signaling

Prous Science announces the addition of Chronic Rhinosinusitis to the Drug R&D Backgrounders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...